Heart Failure — 3D Assessment of RV Function in Patients Undergoing LVAD Implantation
Citation(s)
Amsallem M, Mercier O, Kobayashi Y, Moneghetti K, Haddad F Forgotten No More: A Focused Update on the Right Ventricle in Cardiovascular Disease. JACC Heart Fail. 2018 Nov;6(11):891-903. doi: 10.1016/j.jchf.2018.05.022. Epub 2018 Oct 10.
Dragulescu A, Grosse-Wortmann L, Fackoury C, Mertens L Echocardiographic assessment of right ventricular volumes: a comparison of different techniques in children after surgical repair of tetralogy of Fallot. Eur Heart J Cardiovasc Imaging. 2012 Jul;13(7):596-604. doi: 10.1093/ejechocard/jer278. Epub 2011 Dec 22.
Friedberg MK, Redington AN Right versus left ventricular failure: differences, similarities, and interactions. Circulation. 2014 Mar 4;129(9):1033-44. doi: 10.1161/CIRCULATIONAHA.113.001375. No abstract available.
Haddad F, Doyle R, Murphy DJ, Hunt SA Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008 Apr 1;117(13):1717-31. doi: 10.1161/CIRCULATIONAHA.107.653584. No abstract available.
Kim J, Cohen SB, Atalay MK, Maslow AD, Poppas A Quantitative Assessment of Right Ventricular Volumes and Ejection Fraction in Patients with Left Ventricular Systolic Dysfunction by Real Time Three-Dimensional Echocardiography versus Cardiac Magnetic Resonance Imaging. Echocardiography. 2015 May;32(5):805-12. doi: 10.1111/echo.12715. Epub 2014 Aug 11.
Lu MJ, Zhong WH, Liu YX, Miao HZ, Li YC, Ji MH Sample Size for Assessing Agreement between Two Methods of Measurement by Bland-Altman Method. Int J Biostat. 2016 Nov 1;12(2):/j/ijb.2016.12.issue-2/ijb-2015-0039/ijb-2015-0039.xml. doi: 10.1515/ijb-2015-0039.
Mogelvang J, Stubgaard M, Thomsen C, Henriksen O Evaluation of right ventricular volumes measured by magnetic resonance imaging. Eur Heart J. 1988 May;9(5):529-33. doi: 10.1093/oxfordjournals.eurheartj.a062539.
Otani K, Nabeshima Y, Kitano T, Takeuchi M Accuracy of fully automated right ventricular quantification software with 3D echocardiography: direct comparison with cardiac magnetic resonance and semi-automated quantification software. Eur Heart J Cardiovasc Imaging. 2020 Jul 1;21(7):787-795. doi: 10.1093/ehjci/jez236.
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8. doi: 10.1016/j.echo.2010.05.010. No abstract available.
Schneider M, Binder T Echocardiographic evaluation of the right heart. Wien Klin Wochenschr. 2018 Jul;130(13-14):413-420. doi: 10.1007/s00508-018-1330-3. Epub 2018 Mar 19.
Shimada YJ, Shiota M, Siegel RJ, Shiota T Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study. J Am Soc Echocardiogr. 2010 Sep;23(9):943-53. doi: 10.1016/j.echo.2010.06.029.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.